Today: 9 April 2026
Subscribe
Browse Category

TSX:6758.T 10 July 2025 - 12 November 2025

Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Japan Stocks Today (Nov 13, 2025): Dow’s Record High, Yen Near 155, Producer Prices at 8:50 JST, and SoftBank/Sony in Focus — What to Know Before Tokyo Opens

Tokyo stocks set to open steady to firmer Thursday after the Dow closed above 48,000 for the first time and the yen weakened to 154.79 against the dollar. Nikkei futures traded near 51,200 late in U.S. hours. Japan’s October producer prices and a ¥2.4 trillion 5-year JGB auction are due this morning. Traders watch SoftBank, Sony, Toyota, and trading houses after recent announcements.
12 November 2025
···
The Ultimate 2025 (Q1) Flagship Smartphone Showdown: Apple vs Samsung vs Google & More

The Ultimate 2025 (Q1) Flagship Smartphone Showdown: Apple vs Samsung vs Google & More

Apple’s iPhone 15 Pro series uses a Grade 5 titanium frame, making it about 18 grams lighter than before. Samsung’s Galaxy S24 Ultra features a reinforced titanium alloy chassis and a large camera housing with built-in S-Pen. OnePlus 13 debuts Ceramic Guard glass and IP69 water/dust resistance. Google Pixel 9 Pro offers a 6.7-inch flat OLED display with up to 2400 nits peak brightness.
10 July 2025
······

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop